The cultivable human oral gluten-degrading microbiome and its potential implications in coeliac disease and gluten sensitivity  M. Fernandez-Feo, G. Wei,

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Applying proteomic technology to clinical virology
L. Boyanova  Clinical Microbiology and Infection 
Rapid and sensitive diagnosis of Toxoplasma gondii infections by PCR
Gut bacterial microbiota and obesity
Activity of quinupristin–dalfopristin in invasive isolates of Streptococcus pneumoniae from Italy  A. Pantosti, F. D'Ambrosio, E. Bordi, A. Scotto d'Abusco,
D. Khalil, M. Hultin, M.U. Rashid, B. Lund 
Risk factors for cryptococcal infection among patients with rheumatoid arthritis receiving different immunosuppressive medications  T.-L. Liao, Y.-M.
Migrant health—a cause for concern?
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Increased conjugation frequencies in clinical Enterococcus faecium strains harbouring the enterococcal surface protein gene esp  B. Lund, H. Billström,
Human papillomavirus (HPV) infection and genotype frequency in the oral mucosa of newborns in Milan, Italy  M. Martinelli, A. Zappa, S. Bianchi, E. Frati,
J.-P. Van geertruyden  Clinical Microbiology and Infection 
Virological tools to diagnose and monitor hepatitis C virus infection
A comparison of three real-time PCR assays for the confirmation of Neisseria gonorrhoeae following detection of N. gonorrhoeae using Roche COBAS AMPLICOR 
Analysis of differentially expressed proteins involved in hand, foot and mouth disease and normal sera  L. Deng, H.-L. Jia, C.-W. Liu, K.-H. Hu, G.-Q.
Evidence of transmission of verocytotoxin-producing Escherichia coli O111 from a cattle stable to a child  E. Møller Nielsen, C. Jensen, D. Lau Baggesen 
S. Silva, S. J. Hooper, M. Henriques, R. Oliveira, J. Azeredo, D. W
R. Cantón  Clinical Microbiology and Infection 
P. Nordmann, L. Poirel  Clinical Microbiology and Infection 
Louis Pasteur, from crystals of life to vaccination
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Dermatitis by Dermatophilus congolensis
An eye-catching acanthocephalan
Rapid detection of the recently emerged Bordetella pertussis strains with the ptxP3 pertussis toxin promoter allele by real-time PCR  T. Kallonen, J.
Surveillance of Legionnaires’ disease in Austria
Vector control: a cornerstone in the malaria elimination campaign
C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins
The ability of Group A streptococcus to adhere to immortalized human skin versus throat cell lines does not reflect their predicted tissue tropism  J.M.S.
A comparison of three real-time PCR assays for the confirmation of Neisseria gonorrhoeae following detection of N. gonorrhoeae using Roche COBAS AMPLICOR 
Training for the infectious diseases speciality in Norway
Rickettsia prowazekii infection of endothelial cells increases leukocyte adhesion through αvβ3 integrin engagement  Y. Bechah, C. Capo, G. Grau, D. Raoult,
CMI editorial report 2011 Clinical Microbiology and Infection
Analysis of differentially expressed proteins involved in hand, foot and mouth disease and normal sera  L. Deng, H.-L. Jia, C.-W. Liu, K.-H. Hu, G.-Q.
Elements of design: the knowledge on which we build
Levofloxacin in the treatment of ventilator-associated pneumonia
Isolation rate, T-serotyping and susceptibility to antibiotics of Group A Streptococcus from pediatric infections in Athens*   M. Kanellopoulou, A. Makri,
Metagenomics and probiotics
Effect of antioxidants on the immune response of Helicobacter pylori
The practice of travel medicine in Europe
T.M. File  Clinical Microbiology and Infection 
Systematic review of antibiotic consumption in acute care hospitals
Abstracts cont. Clinical Microbiology and Infection
Pandemic lineages of extraintestinal pathogenic Escherichia coli
P.M. Hawkey  Clinical Microbiology and Infection 
R. Slinger, I. Moldovan, N. Barrowman, F. Chan 
A.P. Underwood, J. Green  Clinical Microbiology and Infection 
Circulation of international clones of levofloxacin non-susceptible Streptococcus pneumoniae in Taiwan  Y.-C. Hsieh, L.-Y. Chang, Y.-C. Huang, H.-C. Lin,
S. Stepanović, V. Djukić, V. Djordjević, S. Djukić 
Increasing numbers of hospitalizations and deaths with mention of Clostridium difficile infection, north-eastern Italy, 2008–2013  U. Fedeli, E. Schievano,
Statin use and clinical outcomes among pneumonia patients
Clinical Microbiology and Infection
K. Kaier, N.T. Mutters, U. Frank  Clinical Microbiology and Infection 
The atypical pneumonias: clinical diagnosis and importance
Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe  Robert D. Fox  Clinical Microbiology.
Abstracts Clinical Microbiology and Infection
Modelling during an emergency: the 2009 H1N1 influenza pandemic
New oral cephalosporins in pediatric community-acquired infections
Multidrug resistance-encoding plasmid from Aeromonas sp. strain P2GI
O. Megged, A.M. Yinnon, D. Raveh, B. Rudensky, Y. Schlesinger 
Are we losing the fight against malaria one more time?
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
Typing of Clostridium difficile
Impact of antibiotic restrictions: the patient's perspective
Comparative study of pediculicidal effect of medical plants
Abstracts Clinical Microbiology and Infection
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Presentation transcript:

The cultivable human oral gluten-degrading microbiome and its potential implications in coeliac disease and gluten sensitivity  M. Fernandez-Feo, G. Wei, G. Blumenkranz, F.E. Dewhirst, D. Schuppan, F.G. Oppenheim, E.J. Helmerhorst  Clinical Microbiology and Infection  Volume 19, Issue 9, Pages E386-E394 (September 2013) DOI: 10.1111/1469-0691.12249 Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 Gliadin zymography of selected oral strains: 150-μl aliquots of cells (OD620 5.0) were applied per lane. Lane 1, WSA-2B (Rothia mucilaginosa); lane 2: WSA-8 (Rothia aeria); lane 3: WSA-21B (R. mucilaginosa); lane 4: PA-20b (Actinomyces odontolyticus); lane 5: PA-12 (Streptococcus mitis); lane 6: PA-21 (Streptococcus sp. HOT-071); lane 7: PA-2b (Neisseria mucosa); lane 8: PA-90R (Capnocytophaga sputigena). Clinical Microbiology and Infection 2013 19, E386-E394DOI: (10.1111/1469-0691.12249) Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 2 Kinetics of gliadin degradation and 33-mer degradation by WSA-2B, PA-20b and PA-90R. Arrows point to the major protein component in the gliadin preparation at ~37 kD (SDS gels, left panels) and the 33-mer (RP-HPLC chromatograms, right panels). The cell densities used for the incubations were OD620 1.2 for WSA-2B and PA-20b and OD620 0.2 for PA-90R. The final concentration of mixed gliadins and 33-mer peptide were 250 μg/ml. Degradation mixtures were analysed at t = 0, 2 h and 5 h (strains WSA-2B and PA-20b) and t = 0, 4 h and 8 h (strain PA90R). Clinical Microbiology and Infection 2013 19, E386-E394DOI: (10.1111/1469-0691.12249) Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 3 pH gluten peptide degrading activity profiles of WSA-21B, PA-20b and PA-90R. Strains were suspended to a final OD620 1.2 in Tris solutions with pH values adjusted to pH 3.0, 5.0, 7.0 and 9.0, and hydrolysis of Z-YPQ-pNA (final concentration 200 μM) was monitored spectrophotometrically at 405 nm over a 0–480 min time interval. (a) WSA-21B; (b) PA-20b; (c) PA-90R. (d) Equal volumes of the three strains were mixed at pH 3.0, pH 7.0, or at pH 3.0 followed by adjustment of the pH after 1.5 h to 7.0. Z-YPQ-pNA hydrolysis in the three suspensions is shown. Clinical Microbiology and Infection 2013 19, E386-E394DOI: (10.1111/1469-0691.12249) Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions